FOLH1 and posterior cortical atrophy: In the PSMA-PET group, the detection rates of PCa and csPCa were significantly higher in PSMA-PET-positive compared with PSMA-PET-negative patients (23/25, 92.0% vs 3/35, 8.6%, χ2 = 41.34, P < 0.01 and 22/25, 88.0% vs 2/35, 5.7%, χ2 = 42.68, P < 0.01, respectively) (Fig. 3, Table 2).